Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer, vol.136, pp.359-386, 2015. ,
Functional status and mortality in older women with gynecological cancer, J. Gerontol. A Biol. Sci. Med. Sci, vol.68, pp.1129-1133, 2013. ,
Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer, Am. J. Obstet. Gynecol, vol.197, pp.676-677, 2007. ,
Trends in relative survival for ovarian cancer from, Obstet. Gynecol, vol.125, pp.1345-1352, 1975. ,
Ovarian cancer. Survival and treatment differences by age, Cancer, vol.71, pp.524-529, 1993. ,
Improved estimates of cancer-specific survival rates from population-based data, J. Natl. Cancer Inst, vol.102, pp.1584-1598, 2010. ,
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis, J. Clin. Oncol, vol.20, pp.1248-1259, 2002. ,
Ovarian cancer in the octogenarian: Does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?, Gynecol. Oncol, vol.110, pp.133-139, 2008. ,
Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group study, Cancer, vol.71, pp.618-627, 1993. ,
Ovarian cancer in the elderly: An analysis of surveillance, epidemiology, and end results program data, Am. J. Obstet. Gynecol, vol.154, pp.639-647, 1986. ,
National survey of ovarian carcinoma. IV: Patterns of care and related survival for older patients, Cancer, vol.73, pp.377-383, 1994. ,
Surgical care of elderly women with ovarian cancer: A population-based perspective, Gynecol. Oncol, vol.99, pp.352-357, 2005. ,
Management of ovarian cancer in patients older than 80 years of Age, Gynecol. Oncol, vol.73, pp.137-139, 1999. ,
Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience, Cancer, vol.71, pp.606-614, 1993. ,
Participation of patients 65 years of age or older in cancer clinical trials, J. Clin. Oncol. Oncol, vol.21, pp.1383-1389, 2003. ,
Epithelial ovarian cancer in the elderly. The Memorial Sloan-Kettering Cancer Center experience, Cancer, vol.71, pp.634-637, 1993. ,
Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U, vol.94, pp.2766-2792, 2002. ,
A pilot study evaluating predictors of postoperative outcomes after major abdominal surgery: Physiological capacity compared with the ASA physical status classification system, Br. J. Anaesth, vol.104, pp.465-471, 2010. ,
New FIGO classification of ovarian, fallopian tube and primary peritoneal cancer, Pathologe, vol.35, pp.322-326, 2014. ,
Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: A retrospective French multicentric study, Int. J. Gynecol. Cancer, vol.22, pp.1337-1343, 2012. ,
Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann. Surg, vol.240, pp.205-213, 2004. ,
Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer, Gynecol. Oncol. Oncol, vol.98, pp.403-408, 2005. ,
Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: A population-based study, J. Clin. Oncol, vol.20, pp.173-178, 2002. ,
Older women as the focus for research and treatment of ovarian cancer. An overview for the National Institute on Aging, National Cancer Institute, Cancer, vol.71, pp.514-516, 1993. ,
Clinical trials in elderly ovarian cancer patients-Does it make sense? Onkologie, vol.35, pp.73-74, 2012. ,
Ovarian cancer management in the oldest old: Improving outcomes and tailoring treatments, Aging Dis, vol.8, pp.677-684, 2017. ,
Elderly patients' participation in clinical trials, Perspect Clin. Res, vol.6, pp.184-189, 2015. ,
Trends in the receipt of guideline care and survival for women with ovarian cancer: A population-based study, Gynecol. Oncol, vol.145, pp.486-492, 2017. ,
Age contrasts in patients with advanced epithelial ovarian cancer. The M.D. Anderson Cancer Center experience, Cancer, vol.71, pp.638-643, 1993. ,
Underrepresentation of patients 65 years of age or older in cancer-treatment trials, N. Engl. J. Med, vol.341, pp.2061-2067, 1999. ,
Enrollment of older patients in cancer treatment trials in Canada: Why is age a barrier?, J. Clin. Oncol, vol.21, pp.1618-1623, 2003. ,
Representation of older patients in cancer treatment trials, Cancer, vol.74, pp.2208-2214, 1994. ,
Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer, Gynecol. Oncol, vol.147, pp.104-109, 2017. ,
Ovarian cancer in elderly patients: Patterns of care and treatment outcomes according to age and modified frailty index, Int. J. Gynecol. Cancer, vol.27, pp.1863-1871, 2017. ,
Gynecological malignancies in elderly patients: Is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study, Gynecol. Oncol. Oncol, vol.85, pp.445-450, 2002. ,
Optimising treatment of elderly patients with ovarian cancer: Improving their enrollment in clinical trials, Drugs Aging, vol.22, pp.95-100, 2005. ,
Age contrasts in clinical characteristics and pattern of care in patients with epithelial ovarian cancer, Gynecol. Oncol. Oncol, vol.86, pp.274-278, 2002. ,
Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy, Gynecol. Oncol, vol.106, pp.381-387, 2007. ,
Patterns and outcomes of chemotherapy for elderly patients with stage II ovarian cancer: A population-based study, Gynecol. Oncol, vol.92, pp.293-299, 2004. ,
Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged > or =70 years with advanced ovarian cancer-A study by the AGO OVAR Germany, Ann. Oncol, vol.18, pp.282-287, 2007. ,
Completion of adjuvant chemotherapy and use of health services for older women with epithelial ovarian cancer, J. Clin. Oncol, vol.29, pp.3921-3926, 2011. ,
ToleRability of BevacizUmab in elderly ovarian cancer patients (TURBO study): A case-control study of a real-life experience, J. Gynecol. Oncol, vol.31, 2020. ,
A phase 3 trial of bevacizumab in ovarian cancer, N. Engl. J. Med, vol.365, pp.2484-2496, 2011. ,
Cancer burden in the aged: An epidemiologic and demographic overview, Cancer, vol.80, pp.1273-1283, 1997. ,
Ovarian cancer in the elderly: Impact of surgery on morbidity and survival, Eur. J. Surg. Oncol, vol.37, pp.537-542, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00696626
Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer, Gynecol. Oncol, vol.103, pp.1048-1053, 2006. ,
Elderly ovarian cancer patients: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO), Eur. J. Cancer, vol.60, pp.101-106, 2016. ,
Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes, Gynecol. Oncol, vol.115, pp.334-338, 2009. ,
Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology, J. Gynecol. Obstet. Hum. Reprod, vol.48, pp.369-378, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02088076
Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: Systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up), J. Gynecol. Obstet. Hum. Reprod, vol.48, pp.379-386, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02088076
A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms, N. Engl. J. Med, vol.380, pp.822-832, 2019. ,
Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer, N. Engl. J. Med, vol.379, pp.2495-2505, 2018. ,
Hyperthermic intraperitoneal chemotherapy in ovarian cancer, N. Engl. J. Med, vol.378, pp.230-240, 2018. ,